BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 21452930)

  • 1. The dual role of p53: DNA protection and antioxidant.
    Borrás C; Gómez-Cabrera MC; Viña J
    Free Radic Res; 2011 Jun; 45(6):643-52. PubMed ID: 21452930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of p53 with tumor suppressive and oncogenic signaling pathways to control cellular reactive oxygen species production.
    Ladelfa MF; Toledo MF; Laiseca JE; Monte M
    Antioxid Redox Signal; 2011 Sep; 15(6):1749-61. PubMed ID: 20919943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor protein 53-induced nuclear protein 1 is a major mediator of p53 antioxidant function.
    Cano CE; Gommeaux J; Pietri S; Culcasi M; Garcia S; Seux M; Barelier S; Vasseur S; Spoto RP; Pébusque MJ; Dusetti NJ; Iovanna JL; Carrier A
    Cancer Res; 2009 Jan; 69(1):219-26. PubMed ID: 19118006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Airing out an antioxidant role for the tumor suppressor p53.
    Tomko RJ; Bansal P; Lazo JS
    Mol Interv; 2006 Feb; 6(1):23-5, 2. PubMed ID: 16507747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 pro-oxidant activity in the central nervous system: implication in aging and neurodegenerative diseases.
    Chatoo W; Abdouh M; Bernier G
    Antioxid Redox Signal; 2011 Sep; 15(6):1729-37. PubMed ID: 20849375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Free radicals, metals and antioxidants in oxidative stress-induced cancer.
    Valko M; Rhodes CJ; Moncol J; Izakovic M; Mazur M
    Chem Biol Interact; 2006 Mar; 160(1):1-40. PubMed ID: 16430879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maintenance of genomic integrity by p53: complementary roles for activated and non-activated p53.
    Albrechtsen N; Dornreiter I; Grosse F; Kim E; Wiesmüller L; Deppert W
    Oncogene; 1999 Dec; 18(53):7706-17. PubMed ID: 10618711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ribosomal protein S27-like, a p53-inducible modulator of cell fate in response to genotoxic stress.
    Li J; Tan J; Zhuang L; Banerjee B; Yang X; Chau JF; Lee PL; Hande MP; Li B; Yu Q
    Cancer Res; 2007 Dec; 67(23):11317-26. PubMed ID: 18056458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redox control and interplay between p53 isoforms: roles in the regulation of basal p53 levels, cell fate, and senescence.
    Hafsi H; Hainaut P
    Antioxid Redox Signal; 2011 Sep; 15(6):1655-67. PubMed ID: 21194382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The subcellular distribution of the p53 tumour suppressor, and organismal ageing.
    Wesierska-Gadek J; Schmid G
    Cell Mol Biol Lett; 2005; 10(3):439-53. PubMed ID: 16217555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hsp27 modulates p53 signaling and suppresses cellular senescence.
    O'Callaghan-Sunol C; Gabai VL; Sherman MY
    Cancer Res; 2007 Dec; 67(24):11779-88. PubMed ID: 18089808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute acidic exposure induces p53-mediated oxidative stress and DNA damage in tilapia (Oreochromis niloticus) blood cells.
    Mai WJ; Yan JL; Wang L; Zheng Y; Xin Y; Wang WN
    Aquat Toxicol; 2010 Nov; 100(3):271-81. PubMed ID: 20739073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased ROS generation and p53 activation in alpha-lipoic acid-induced apoptosis of hepatoma cells.
    Simbula G; Columbano A; Ledda-Columbano GM; Sanna L; Deidda M; Diana A; Pibiri M
    Apoptosis; 2007 Jan; 12(1):113-23. PubMed ID: 17136495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of p53-mediated apoptosis as a crucial anti-tumor response to genomic instability: lessons from mouse models.
    Attardi LD
    Mutat Res; 2005 Jan; 569(1-2):145-57. PubMed ID: 15603759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed ageing through damage protection by the Arf/p53 pathway.
    Matheu A; Maraver A; Klatt P; Flores I; Garcia-Cao I; Borras C; Flores JM; Viña J; Blasco MA; Serrano M
    Nature; 2007 Jul; 448(7151):375-9. PubMed ID: 17637672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Berberine induces p53-dependent cell cycle arrest and apoptosis of human osteosarcoma cells by inflicting DNA damage.
    Liu Z; Liu Q; Xu B; Wu J; Guo C; Zhu F; Yang Q; Gao G; Gong Y; Shao C
    Mutat Res; 2009 Mar; 662(1-2):75-83. PubMed ID: 19159633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiological ageing: role of p53 and PARP-1 tumor suppressors in the regulation of terminal senescence.
    Wesierska-Gadek J; Ranftler C; Schmid G
    J Physiol Pharmacol; 2005 Mar; 56 Suppl 2():77-88. PubMed ID: 16077192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 Protein is activated by Pin1: and also by Cu-SOD prion-like enzyme.
    Wiseman A
    Med Hypotheses; 2005; 65(1):32-4. PubMed ID: 15893113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 protein or BID protein select the route to either apoptosis (programmed cell death) or to cell cycle arrest opposing carcinogenesis after DNA damage by ROS.
    Wiseman A
    Med Hypotheses; 2006; 67(2):296-9. PubMed ID: 16580789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.